Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews
Abigail Norris Turner(University of Leeds), Charlotte Ellertson(Unknown), Alana E. De Kock(University of Cape Town), Amy Meehan-Ritter(University of California, Berkeley), Mohlatlego Sebola(University of Limpopo), A A Hoosen(University of Limpopo), Nicol Coetzee(University of Cape Town), Kelly Blanchard(Ibis Reproductive Health)
Cited by 64
Related Papers
Vaginal Misoprostol Administered 1, 2, or 3 Days After Mifepristone for Early Medical Abortion
|JAMA|2000|215
New estimates of the effectiveness of the Yuzpe regimen of emergency contraception
|Contraception|1998|187
Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion
|American Journal of Obstetrics and Gynecology|1997|179